News Sentiment

OCUL sentiment intelligence

Ocular Therapeutix Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 63 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 10.20 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 54

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+5.8% over one week, +14.1% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Citizens reiterates Ocular Therapeutix stock rating on Dextenza sales

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction 5.8% Price confirming higher
Trend fit Trend inactive 14.1% over four weeks
Fair value 25.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 17
Neutral 42
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 54
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 18
TradingView 7
simplywall.st 5
Investing.com 4
Simply Wall Street 4
GlobeNewswire 3
Stock Titan 3
Finviz 2

Event Lens

What the news is about

Classified themes
Market update 34
Earnings 19
Analyst action 5
Balance sheet 2
Regulatory and legal 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 63